Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.

Literature DB >> 25084197

CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.

Abstract

Entities: Gene

Keywords: CPIC; CYP2D6; clinical implementation; cytochrome P450; drug-metabolizing enzymes; genetic variation; pharmacogenetics

Mesh：

Substances：
Cytochrome P-450 CYP2D6

Year: 2014 PMID： 25084197 DOI： 10.2217/pgs.14.27

Source DB: PubMed Journal: Pharmacogenomics ISSN： 1462-2416 Impact factor: 2.533

Keyword Cloud
Cited

× No keyword cloud information.

3 in total

Review 1. Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.

Authors: Alexander D Roth; Moo-Yeal Lee
Journal: Biomed Res Int Date: 2017-01-04 Impact factor: 3.411

2. The impact of CYP2D641* on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva.

Authors: Ye Jin; Shuquan Zhang; Pei Hu; Xin Zheng; Xiaoduo Guan; Rui Chen; Shuyang Zhang
Journal: Front Pharmacol Date: 2022-08-30 Impact factor: 5.988

3. CYP2D6 Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of CYP2D6^∗10 on Interindividual Variation in a Chinese Population.

Authors: Rui Chen; Xin Zheng; Pei Hu
Journal: Front Pharmacol Date: 2017-05-02 Impact factor: 5.810

3 in total

CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.

Review 1. Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.

2. The impact of CYP2D6*41 on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva.

3. CYP2D6 Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of CYP2D6∗10 on Interindividual Variation in a Chinese Population.

2. The impact of CYP2D641* on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva.

3. CYP2D6 Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of CYP2D6^∗10 on Interindividual Variation in a Chinese Population.